CX3CL1/CX3CR1 axis alleviates inflammation and apoptosis in human nucleus pulpous cells via M2 macrophage polarization.

CX3C chemokine ligand 1 (CX3CL1) belongs to the CX3C chemokine family and is involved in various disease processes. However, its role in intervertebral disc degeneration (IDD) remains to be elucidated. In the present study, western blotting, reverse transcription-quantitative PCR and ELISA assays were used to assess target gene expression. In addition, immunofluorescence and TUNEL staining were used to assess macrophage infiltration, monocyte migration and apoptosis. The present study aimed to reveal if and how CX3CL1 regulates IDD progression by exploring its effect on macrophage polarization and apoptosis of human nucleus pulposus cells (HNPCs). The data showed that CX3CL1 bound to CX3C motif chemokine receptor 1 (CX3CR1) promoted the M2 phenotype polarization via JAK2/STAT3 signaling, followed by increasing the secretion of anti-inflammatory cytokines from HNPCs. In addition, HNPC-derived CX3CL1 promoted M2 macrophage-derived C-C motif chemokine ligand 17 release thereby reducing the apoptosis of HNPCs. In clinic, the reduction of mRNA and protein levels CX3CL1 in degenerative nucleus pulposus tissues (NPs) was measured. Increased M1 macrophages and pro-inflammatory cytokines were found in NPs of IDD patients with low CX3CL1 expression. Collectively, these findings suggested that the CX3CL1/CX3CR1 axis alleviates IDD by reducing inflammation and apoptosis of HNPCs via macrophages. Therefore, targeting CX3CL1/CX3CR1 axis is expected to produce a new therapeutic approach for IDD.

A new quantitative method using glucose for analysis of endodontic leakage.

OBJECTIVE: The purpose of this study was to introduce a new method for quantitative testing of endodontic leakage. STUDY DESIGN: Eighty straight maxillary anterior teeth were divided randomly into 3 experimental groups of 20 samples each and 2 control groups. The experimental groups were prepared using the modified double-flared technique and obturated by lateral compaction of cold gutta-percha with Pulp Canal Sealer EWT, Sealapex, or AH Plus sealer. With the leakage test device, coronal 1 mol/L glucose solution was forced under a hydrostatic pressure of 1.5 kPa toward the apical part of the root. Leakage was measured by the concentration of leaked glucose in apical reservoir at 1, 2, 4, 7, 10, 15, 20, and 30 days with the enzymatic glucose oxidase method. RESULTS: No significant difference of sealing ability was found among 3 test groups at 1, 2, 4, and 7 days. From the tenth day, Pulp Canal Sealer EWT showed the highest leakage, and the leakage was not significantly different between Sealapex and AH Plus. CONCLUSIONS: The quantitative method is sensitive, nondestructive, and clinically relevant. Pulp Canal Sealer EWT showed more leakage than Sealapex and AH Plus in most observation time.